Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.6M Sell
42,550
-3,510
-8% -$283K 0.04% 288
2026
Q1
$3.26M Sell
46,060
-3,119
-6% -$234K 0.04% 288
2025
Q4
$3.92M Sell
49,179
-4,108
-8% -$325K 0.05% 236
2025
Q3
$4.39M Buy
53,287
+450
+0.9% +$35.4K 0.06% 221
2025
Q2
$4.25M Sell
52,837
-576
-1% -$44.4K 0.06% 220
2025
Q1
$4.29M Sell
53,413
-9,682
-15% -$805K 0.07% 203
2024
Q4
$5.15M Sell
63,095
-3,449
-5% -$287K 0.07% 178
2024
Q3
$5.44M Buy
66,544
+8,322
+14% +$622K 0.08% 175
2024
Q2
$4.07M Buy
58,222
+44,402
+321% +$3.17M 0.07% 189
2024
Q1
$1.02M Buy
13,820
+2,478
+22% +$173K 0.03% 271
2023
Q4
$750K Buy
+11,342
New +$710K 0.02% 314
2018
Q2
Sell
-4,843
Closed -$222K 260
2018
Q1
$222K Sell
4,843
-229
-5% -$11.1K 0.03% 260
2017
Q4
$256K Buy
5,072
+111
+2% +$5.85K 0.03% 245
2017
Q3
$258K Sell
4,961
-366
-7% -$17.8K 0.03% 234
2017
Q2
$261K Sell
5,327
-776
-13% -$36K 0.04% 227
2017
Q1
$287K Buy
+6,103
New +$291K 0.04% 206

Other funds holding MET

Choreo LLC's MET Position: Q2 2026 in Review

Choreo LLC reduced its MetLife (MET) stake by 7.6% in Q2 2026, selling an estimated $283K and leaving 42,550 shares worth $3.6M. The position accounts for 0.04% of the portfolio, ranked #288.

Choreo LLC first reported a position in MET in Q1 2017 and has held it in 16 quarters since. The position peaked at $5.44M in Q3 2024. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Choreo LLC held 42,550 shares of MetLife worth $3.6M as of Q2 2026.
  • Choreo LLC sold 3,510 MetLife shares in Q2 2026, an estimated $283K.
  • MetLife made up 0.04% of Choreo LLC's portfolio in Q2 2026, its #288 holding.
  • Choreo LLC first reported a position in MetLife in Q1 2017 and has held it in 16 quarters since.
  • Choreo LLC's MetLife position peaked at $5.44M in Q3 2024.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.